Website intended for a NZ health professional readership
Honorary professor of general practice Campbell Murdoch played a key role in the recognition of chronic fatigue syndrome, 30 years ago. He reflects on then and now as studies suggest “Long COVID” is associated with an increased number of people experiencing CFS
1.Editorial, 7 October 2020. Long COVID: let patients help define long-lasting COVID symptoms. Nature 586,170
2.Poore M, Snow P and Paul C. An unexplained illness in West Otago. NZ Med J 1984:97;351-4.
3.Snow P. Reminiscences of the chronic fatigue syndrome. NZ Family Physician 2002:29;385-6.
4.Sandler CX and Lloyd AR Chronic fatigue syndrome: progress and possibilities. Med J Aust 2020 May;212(9):428-433.
5.Lombardi VC et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009 23 Oct;326(5952):585-9.
6.Murdoch JC. Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. NZ Med J 1988;101:511-2.
7.Oldstone MBA Viral alteration of cell function. Scientific American August 1989:34-40.
8.Mackay A. A neuro-inflammatory model can explain the onset, symptoms and flare-ups of myalgic encephalomyelitis/chronic fatigue syndrome. J Prim. Health Care 2019;11:300-307.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
